Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antirheumatics/vermoeidheid

De link wordt op het klembord opgeslagen
Bladzijde 1 van 17 resultaten
Linking data from the renowned, representative, population-based Nord-Trøndelag Health studies of adolescents (Young-HUNT, 1995-2019) to longitudinal, individual data from the Norwegian prescription Database (NorPD) (2004-2020) provides a unique, longitudinal dataset which will be examined in this

MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Study design: Up to 30 adults, 25-75 yrs. of age may be recruited and enrolled to participate in a cross-sectional study. Subjects will be divided between two cohorts: 1) persons with early RA (n=15) and 2) age-, sex-, Body Mass Index (BMI)-matched healthy controls (n=15). The goal is to have equal

Cognitive Behavioural Therapy for Insomnia on Sleep in Rheumatoid Arthritis.

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Introduction: More than half of patients with rheumatoid arthritis has concomitant insomnia. Insomnia may modify pain, fatigue, quality of life and comorbidities which many patients struggle with. To address this issue, a nurse led sleep outpatient clinic was established in 2015 at the Center for

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The study duration per patient is expected to be approximately 32 weeks, with up to 4-week screening, 24 weeks treatment, and 2-4 weeks post-treatment observations.

REMission INDuction in Very Early Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Secondary endpoints: Phase I (Remission induction): - The proportion of patients on MTX/HCQ/GC in remission, defined as DAS28<2.6, at week 12 or week 24 after start of treatment. - The proportion of patients on MTX/GOL in sustained remission, defined as DAS28<2.6 with max 4 swollen joints of the

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Background: Primary Sjögren's syndrome (pSS) is a chronic inflammatory and lymphoproliferative disease with autoimmune features. pSS is characterised by a progressive lymphocytic infiltration of the exocrine glands, notably the lacrimal and salivary glands. The main clinical features are a

Effect of Andosan in Patients With Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Main aim: Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) leads to a clinical, biochemical and genetical improvement in RA. The experiment will be carried out for 21 days in 15 eligible RA patients. In order to increase the scientific value of the project we

The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis Patients

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Rheumatoid arthritis (RA) is a chronic inflammatory disease that impacts approximately 1% of all Canadians. RA is associated with increased mortality, decreased life expectancy and increased morbidity, which is primarily attributable to an increased risk of cardiovascular disease (CVD). Traditional

A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in

Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Rheumatoid arthritis (RA) is the most prevalent (about 1%) inflammatory rheumatic disorder. Interleukin-6 (IL-6) has emerged as a potential therapeutic target in RA. This is based on the greater understanding of the role this cytokine can play in various aspects of the pathogenesis of RA. It has

An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in

A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
I. Rationale Inflammatory arthritis is one of the most prevalent diseases in Canada, affecting about 10% of Canadian adults (Health Canada, 2003). It is a leading cause functional disability, chronic pain, and reduced quality of life, resulting in difficulties at work and at home. Affected

Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Rheumatoid arthritis affects approximately 1% of the adult population, and is a chronic, progressive disease characterized by synovial inflammation. The resulting inflammation leads to destruction of the synovium and surrounding joint tissues, which can result in cartilage destruction, bone erosion

Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
Rheumatoid arthritis affects approximately 1% of the adult population. It is a chronic, progressive disease characterized by synovial inflammation. The resulting inflammation leads to destruction of the synovium and surrounding joint tissues, which can result in cartilage destruction, bone erosion
Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge